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ABSTRACT 
 
 
 
 
The α2 isoform of collagen IV’s noncollagenous 1 domain (α2NC1 or 
canstatin) has shown promise as an anti-cancer molecule, possessing both 
angiostatic and pro-apoptotic properties. This work aims to further the knowledge 
of α2NC1 by conducting a truly in vivo study in which the Gal4-induced 
endogenous overexpression of α2NC1 in Drosophila melanogaster will be used 
to assess the effects of α2NC1 upon normal development as well as 
tumorigenesis. To this end, transgenic fly lines capable of overexpressing α2NC1 
were created. Initial overexpression studies indicated no developmental 
phenotype was caused by abundance of α2NC1. However, future overexpression 
studies in which α2NC1 is exported to its native extracellular location may reveal 
roles for α2NC1 in normal development and/or tumorigenesis. 
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CHAPTER 1 
 
 
INTRODUCTION 
 
 
 One often hears someone mention finding “the cure” for cancer. However, 
no two cancers are exactly alike; rather, “cancer” refers to any unchecked 
proliferation of cells. This rapid growth causes tumors to form. There are several 
factors which confer on tumors the ability to continuously grow and ultimately 
metastasize. Such hallmarks of cancer include the evasion of apoptosis 
(programmed cell death), sustained angiogenesis (the formation of new blood 
vessels), self-sustaining growth signals, and insensitivity to anti-growth signals 
(1). Research focused on each of these cancer hallmarks is needed in order to 
combat the various subtypes that encompass this disease. 
One such area of research focuses on basement membrane, whose 
components play numerous important roles in the formation, growth, and 
spreading of tumors. Basement membrane, or “BM”, is the 50-100nm-thick 
specialized extracellular matrix that lines both layers of epithelial cells and the 
endothelial cells that line blood vessels (2). BM plays an important structural role, 
separating monolayers of epithelia from stroma or neighboring tissue and 
providing support. It is also important in numerous biochemical capacities, as
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components of BM have been shown to modulate signaling across the cell 
membrane (2,3). Such signals promote cell migration, differentiation, and growth 
and can vary depending on the unique microenvironment created by the BM 
components, many of which have tissue-specific isoforms (2,3,4). 
One such component of BM is collagen IV (2,3,4). The genes for collagen 
IV are highly conserved across species (5) and code for six distinct isoforms of 
the α-chain, which differ primarily within their globular C-terminal noncollagenous 
(NC1) domains (2-6). α-chains self-assemble in the extracellular space to form 
the complex collagen IV suprastructure shown in Figure 1.1. In the first step of 
self-assembly, NC1 domains coordinate the association of three α-chains into 
trimers referred to as protomers. Several unique combinations of α-chain 
isoforms have been observed, with α1α1α2 being the most common (2,3,6). Two 
protomers associate into a hexamer of α-chains via thioester bonds between 
conserved methionine and lysine residues present in each NC1. Each 
methionine bonds with the lysine on the opposite NC1 residue, and vice-versa 
(2). Interactions between the N-terminal 7S domains mediate the tetrameric 
association of hexamers to form the “spider-like” shape characteristic of the 
collagen IV matrix (2,3). 
 There are several other components of BM, most of which are proteins 
and glycoproteins (2,3,5). The second-most abundant component is the 
glycoprotein laminin which, like collagen IV, self-assembles into a network 
composed of laminin trimers (in this case, heterotrimers, each consisting of an α, 
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β, and γ subunits). A variety of laminin isoforms contributes to the heterogeneity 
observed within individual BMs and between BMs of various tissues (2,3). 
Additionally, the presence of less abundant collagens (i.e. collagen XV and 
collagen XVIII) lends specificity to particular BMs. Other protein components 
include nidogen/entactin (which links the collagen and laminin scaffolds), 
heparan-sulphate proteoglycans (such as perlecan and agrin, which sequester 
stores of vascular endothelial growth factor), SPARC/BM-40/osteopontin), and 
fibulins (3). Not only are each of these proteins structurally important for BM, but 
nearly all of them have been shown to regulate angiogenesis during remodeling 
(2,3). 
BM is anchored to the basolateral side of epithelium and endothelium 
primarily by interactions between the five G-like (LG) domains of laminin α-chains 
and cell-surface molecules including integrins and dystroglycans (2,3,6,7). 
Specifically, LG1-3 have been shown to bind integrins α3β1, α6β1, α7β1, & 
α6β4, while LG4-5 bind α-dystroglycan (7,8). However, the chemical natures of 
these interactions remain unknown (8). Additionally, interactions between the 
triple-helical region of collagen IV and integrins α1β1 & α2β1 further promote 
cellular adhesion (6). 
BM components are continuously turned over (degraded and reformed) in 
a process called BM remodeling. While BM remodeling occurs at a normal basal 
level in all tissues, it plays a particularly important role in processes such as 
development and angiogenesis. For example, in Drosophila melanogaster each 
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adult tissue begins as an “imaginal disc” or precursor tissue, in the Drosophila 
larva. Each disc is surrounded by a basement membrane which is turned over 
during disc eversion, the process by which the imaginal discs develop into adult 
tissues (9). Due to this critical role of BM remodeling, Drosophila is an excellent 
model organism for studying the effects of BM components on development, a 
research topic with which the reagents created in this study will aid. 
However, the relevance of BM remodeling on development extends well 
beyond the fly, as it is important for the development and partitioning of tissues in 
all multicellular animals (2,3,10,11). For example, in mice and other mammals, 
the specialized basement membrane of the kidney glomerulus (GBM) is formed 
during embryonic development from the remodeling and fusion of two distinct 
BMs – one synthesized by glomerular epithelium and the other by glomerular 
endothelium. Failure of the GBM to form properly will result in an incompletely 
vascularized glomerulus and a leaky blood-urine barrier (11). 
BM remodeling is also required for the proliferation and migration of 
endothelial cells to form new blood vessels in the process of angiogenesis. Not 
only is BM degradation needed in a physical sense, to un-anchor endothelial 
cells and provide space for a new branch of the blood vessel, but many of the 
protein fragments generated during remodeling promote angiogenesis and 
endothelial cell migration (2,3). Furthermore, stores of vascular endothelial 
growth factor (VEGF) that were previously sequestered in the BM are released 
during remodeling (2,3). 
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As previously mentioned, angiogenesis is critical for tumor growth and 
metastasis, as new blood vessels are needed if the growing tumor is to receive 
the nutrients required for rapid and continued growth. Tumors often therefore 
upregulate factors, such as matrix metalloproteases (MMPs), which degrade BM 
and promote blood vessel formation (5). In addition to providing nutrients, these 
new vessels also provide access to the bloodstream – a single cancerous cell 
may break off from the primary tumor, enter the blood stream, and exit the blood 
stream in another tissue, forming secondary tumors (Figure 1.2). This is the 
process of metastasis and the most clinically devastating feature of cancer. 
Given the numerous pro-angiogenic factors generated by BM remodeling, 
it makes sense that there would be a subsequent signal to “turn off” 
angiogenesis. This seems to be the role of collagen IV’s C-terminal non-
collagenous 1 (NC1) domain. NC1 is one of the smallest and last products to be 
generated by MMPs in the degradation of BM, and several of its isoforms have 
been shown to inhibit angiogenesis (2-6,12-14). One particularly potent isoform is 
that of the α2 chain, or α2NC1 (also called canstatin in some literature). This 
25KDa molecule has been shown to decrease tumor growth and metastasis by 
inhibiting two cancer strategies – sustained angiogenesis and evasion of 
apoptosis. 
 Several studies have demonstrated the angiostatic and pro-apoptotic 
properties of α2NC1 (and other NC1 isoforms) (4,6,12-14). Many of these studies 
were conducted in vitro, using HUVECs (human umbilical vein endothelial cells) 
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to demonstrate decreased growth, migration, & tubal formation as well as 
increased apoptosis of these cells when treated with α2NC1 (4,12). Others were 
conducted in xenograft models, in which human cancer cells were implanted 
subcutaneously in mice to mimic “natural” tumors. These studies showed 
decreased vascularization and growth of implanted tumors when treated with 
α2NC1, either by direct injection or injection of an adenovirus coding for α2NC1 
(4,12,13). Extension of α2NC1’s half-life by fusing it to human serum albumin 
(HSA) resulted in a more dramatic anti-tumor effect and was even shown to 
decrease the levels of metastasis in mice (12,13). Whether or not α2NC1 
promotes apoptosis in tumor cells as well as endothelial cells remains 
controversial, as α2NC1-HSA was shown to have a pro-apoptotic effect but 
unfused α2NC1 was not (4,12-14).  
 Several studies have investigated the mechanism by which α2NC1 elicits 
its effects. One possible anti-angiogenic mechanism of α2NC1 was proposed by 
Petitclerc et al., who suggested that soluble NC1 binds along the triple-helical 
region of collagen IV, thereby disrupting the lateral associations of collagen IV 
with other BM components (i.e. the laminin scaffold) and cell-surface anchors 
(specifically β1 integrins). As a result, the basement membrane assembly 
required for blood vessel formation is obstructed and angiogenesis is prevented 
(6). 
More research has been done, however, based on the results of a study 
by Magnon et al. which found that α2NC1 binds to αv integrins including αvβ3 
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and αvβ5. Interactions between αv integrins and BM components have been 
shown to mediate migration of endothelial and tumor cells. It is therefore thought 
that the binding of α2NC1 to αv integrins blocks BM-integrin interaction and 
thereby inhibits the migration of endothelial and tumor cells seen in angiogenesis 
and metastasis (12). A later study by Magnon et al. demonstrated that due to 
these interactions with αv integrins, α2NC1 is even more effective at decreasing 
tumor angiogenesis and growth when paired with standard radiation therapy, as 
radiation increases expression of αvβ3 and αvβ5 integrins (13). 
 Additionally, α2NC1-integrin interactions have been shown to induce 
caspase-8 dependent apoptosis in endothelial cells by increasing Fas ligand 
expression and downregulating the expression of the anti-apoptotic protein FLIP 
via the disruption of FAK/PI3K/Akt signaling (12,14). Downregulation of FLIP 
decreases the mitochondrial membrane potential, causing the release of 
cytochrome c which results in caspase-9 activation. Caspase-9 dependent 
apoptosis was demonstrated in α2NC1-treated endothelial cells and in α2NC1-
HSA-treated tumor cells (12,14). Furthermore, Petitclerc et al. imply that, like 
previously-studied αvβ3 antagonists, α2NC1 may elicit its pro-apoptotic effect by 
disrupting signal transduction pathways leading to altered expression/activity of 
Bcl-2, Bax, and p53 (6). 
 To further investigate the roles of α2NC1, we proposed a unique in vivo 
study in which α2NC1 would be endogenously overexpressed within a well-
studied model organism, Drosophila melanogaster (the fruit fly). Endogenous 
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overexpression in otherwise wild-type flies will allow us to observe the effects of 
α2NC1 on normal organismal development. In subsequent experiments, α2NC1 
will be overexpressed in flies with mutations in the genes Ras (a conserved and 
much-studied oncogene) and scribble (a conserved cell polarity protein whose 
inactivation disrupts cell polarity, inhibits apoptosis and induces dysplasia). This 
double mutation results in tumors which display features of human metastatic 
tumors. For example, these tumors result in the loss of cell-cell junctions and cell 
polarity (15). By comparing the size and number or tumors observed in α2NC1-
overexpressing flies versus “normal” Ras/scribble flies, we will be able to assess 
α2NC1’s effect upon tumorigenesis. 
To achieve the overexpression of α2NC1 in flies, we chose to utilize the 
powerful UAS-Gal4 binary genetic technique. The various elements of this 
powerful genetic system were originally identified in yeast and manipulated later 
for use in Drosophila. Gal4 is a transcriptional activator which binds to a specific 
sequence of DNA called an upstream activator sequence (UAS), resulting in 
robust transcription of any downstream gene (16) (Figure 1.3). 
In this thesis, work related to cloning of α2NC1 in pUAST and subsequent 
generation of transgenic flies is presented. Two types of UAS- α2NC1 flies were 
created - one with the signal sequence (that aids in the secretion of the protein) 
and the other without this sequence resulting in one set of flies capable of 
secreting the protein and the other set where the secretion would be impaired. 
These two reagents will aid in better understanding of the consequences of 
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α2NC1 overexpression on normal development and tumor progression in a living 
organism. 
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Figure 1.1 Structure of Collagen IV. The collagen IV suprastructure is formed 
by the self-assembly of various α-chains (each ~400nm). In addition to a central 
collagenous domain characterized by a repeated Gly-X-Y motif in which X and Y 
are most often hydroxyproline and hydroxylysine, each α-chain contains an N-
terminal 7S domain and a C-terminal noncollagenous domain. NC1 domains 
initiate the association of three α-chains into a trimer or “protomer”. Two 
protomers interact via their NC1 domains, forming a hexamer. Hexamers interact 
via their 7S domains to form a spider-like tetramer. Bridging of multiple tetramers 
creates the fibrous collagen IV network that comprises more than 50% of the 
basement membrane (2,3). Source: Kalluri, R., et al. (3) 
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Figure 1.2. Angiogenesis and Metastasis. Tumors promote angiogenesis in 
order to receive the nutrients required for continued growth. As illustrated, the 
events of tumor angiogenesis and basement membrane degradation are closely 
linked. New blood vessels provide easy access to the blood stream, allowing 
tumors to metastasize. Source: Adapted from Zetter, B. R. (17) 
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Figure 1.3. Binding of Gal4 to the Upstream Activation Sequence Causes 
Robust Expression of a Downstream Gene (NC1). The UAS-Gal4 system has 
been manipulated for use in Drosophila in order to overexpress genes of interest. 
In this study, crossing transgenic UAS-α2NC1 males with Gal4 driver females 
results in progeny which overexpress NC1. Source: Adapted from Heberlein, U., 
et al. (18) 
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CHAPTER 2 
 
 
METHODS 
 
 
PCR Amplification of α2NC1 cDNA: 
The DNA sequence for α2NC1 was amplified from Viking cDNA via PCR. 
120ng Viking cDNA, 100ng each of primers JO1US and JO1DS (Table 2.1), 5µl 
of 5nM dNTPs (Invitrogen), 5µl of 10X Pfu Turbo Buffer (Agilent Technologies, 
Inc.), 1µl of Pfu (Agilent Technologies, Inc.), and nanopure water to 50µl were 
included in PCR reaction. Thermal cycler conditions were as follows: 5 minutes 
at 94oC, 35X (2 minutes at 94oC, 1 minute at 56oC, 1.5 minutes at 72oC), 10 
minutes at 72oC. The PCR products were run on a 0.8% agarose gel with 
0.6µg/mL ethidium bromide at 100V for 1hr, and the band corresponding to 
α2NC1 (~900bp) was excised and purified using QIAGEN’s Qiaex II Gel 
Extraction Kit, according to the manufacturer’s protocol. 
 
Digestion of α2NC1: 
Purified α2NC1 DNA and Bluescript II SK+ (BS) DNA were each double-
digested with EcoRI and XbaI as follows: 1μg α2NC1 or 40μg BS DNA, 10μl 10X 
Buffer M (Invitrogen), 2.5μl EcoRI (~25U, Invitrogen), 2.5μl (~25U, Invitrogen),
14 
 
and nanopure water to 100μl. Digestions took place in a thermal cycler at 37oC 
for 2 hours. The digests were run on a 0.8% agarose gel with 0.6µg/mL ethidium 
bromide at 100V for 1hr and the bands corresponding to α2NC1 (~900bp) and 
BS (~3000bp) were excised and the DNA purified using the QIAGEN Qiaex II Gel 
Extraction Kit according to the manufacturer’s protocol. 
 
Ligation of α2NC1 into Bluescript II SK+: 
113ng digested BS and 113ng digested α2NC1 (3:1 molar ratio) were 
ligated in a 10µl reaction which also contained 1µl of 10X T4 DNA Ligase Buffer 
(New England Biolabs), 0.5µl T4 DNA Ligase (New England Biolabs), and 
nanopure water. The ligation took place overnight (18 hours) at 10oC. The entire 
ligation (10µl) reaction was used to transform chemically-competent DH5α E. coli 
via heat shock. Heat shock was carried out by incubating the ligation reaction 
with 50µl cells for 20 minutes on ice, followed by 90 seconds on a 42oC heat 
block and another 3 minutes on ice. Cells were then given 300µl LB media and 
incubated at 37oC for 45 minutes. Transformants were selected by growing the 
cells overnight at 37oC on LB-agar with 75µg/mL ampicillin. 
 
Screening of Transformants for Recombinant BS-α2NC1: 
4mL liquid LB/ampicillin (75µg/mL) cultures were inoculated with each of 
the forty-two resulting transformants and grown overnight at 37oC/300rpm. 
Plasmid DNA was isolated from each of these liquid cultures using Qiagen’s 
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QIAprep Spin Miniprep Kit according to the manufacturer’s protocol.  Isolated 
plasmid DNA was run on a 0.8% agarose gel with 0.6µg/mL ethidium bromide at 
100V for 1hr. DNA from putative positive clones was double-digested with EcoRI 
and XbaI for two hours at 37oC (200ng plasmid DNA, 0.5μl each enzyme [~5U, 
Invitrogen], 2μl 10X Buffer M [Invitrogen], nanopure water to 20μl) and run on a 
0.8% agarose gel with 0.6µg/mL ethidium bromide at 100V for 1hr. Miniprepped 
DNA from a confirmed BS-α2NC1 clone was used to transform chemically-
competent DH5α E. coli cells via heat shock (as previously described). A 
resulting colony was used to inoculate a 4mL liquid LB/ampicillin (75µg/mL) 
culture, which was grown for 14 hours at 37oC/300rpm. 500µl of this starter 
culture was used to inoculate a 100mL liquid LB/ampicillin (75µg/mL) culture, 
which was grown up overnight, also at 37oC/300rpm. Plasmid DNA was isolated 
using Qiagen’s Spin Maxiprep Kit according to the manufacturer’s protocol. 
 
Subcloning of α2NC1 from BS-α2NC1 to pUAST: 
 BS-α2NC1 and pUAST were double-digested with EcoRI and XbaI 
(47.3µg of BS-α2NC1 or 42.5µg pUAST, 2.5μl each enzyme [~25U, Invitrogen], 
10μl 10X Buffer M [Invitrogen], nanopure water to 100μl). Digests were run on a 
0.8% agarose gel with 0.6µg/mL ethidium bromide at 100V for 1hr, and the 
bands corresponding to α2NC1 (~900bp) and pUAST (~9000bp) were gel 
extracted using Qiagen’s Qiaex II Gel Extraction Kit according to the 
manufacturer’s protocol. The digested α2NC1 and pUAST were ligated in a 3:1 
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ratio (150ng digested pUAST, 50ng α2NC1, 0.5µl T4 DNA Ligase [200U, NEB], 
1µl 10X Buffer [NEB], nanopure water to 10µl) overnight (14 hours) at 10oC 
using. The entire ligation reaction (10µl) was used to transform chemically-
competent DH5α E. coli using the previously-described heat shock protocol. 
Transformants were selected by growing the cells overnight at 37oC on LB-agar 
plates with 75µg/mL ampicillin. 
 
Screening of Transformants for Recombinant pUAST-α2NC1: 
4mL liquid LB/ampicillin (75µg/mL) cultures were inoculated with each of 
the eighteen resulting transformants and grown overnight at 37oC/300rpm. 
Plasmid DNA was isolated from each of these liquid cultures using Qiagen’s 
QIAprep Spin Miniprep Kit according to the manufacturer’s protocol. Isolated 
plasmid DNA was run on a 0.8% agarose gel with GelRed (Biotium) at 100V for 
1hr. The identity of a putative positive clone was confirmed by amplifying α2NC1 
from it via PCR. The PCR reaction included 1μg plasmid DNA, 100ng each of 
primers JO1US and JO1DS (Table 2.1), 45μl PCR Supermix (Invitrogen), and 
nanopure water to 50μl. Thermal cycler conditions were as follows: 5 minutes at 
94oC, 35X(2 minutes at 94oC, 1 minute at 56oC, 1.5 minutes at 72oC), 10 minutes 
at 72oC. 20μl of the PCR products were run on a 0.8% agarose gel with 
0.6µg/mL ethidium bromide at 100V for 1hr. DNA from the positive clone was 
used to transform chemically-competent DH5α E. coli via heat shock (as 
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previously described) and maxiprep pUAST-α2NC1 using the Qiagen Spin 
Maxiprep Kit according to the manufacturer’s protocol. 
 
Standard Dideoxy Sequencing of pUAST-α2NC1: 
 The α2NC1 DNA sequence was PCR amplified using the following 
conditions: 10pmol of primer UAAS-2 or pUASTrev (Table 2.1), 12ng pUAST-
α2NC1 (template DNA), 2µl 5X BigDye Sequencing Juice, and 2µl 5X buffer. 
Thermal cycler conditions were as follows: 3min at 96oC, 25X (30sec at 96oC, 
15sec at 50oC, 4min at 60oC). Following PCR, amplification products were 
purified from the reaction mix using Qiagen’s DyeEx 2.0 Spin Kit. Samples were 
subsequently evaporated by centrifugation in a centrivap vacuum concentrator 
for 30 minutes at room temperature and resuspended in 20µl formamide buffer. 
Samples were then loaded onto the ABI 3130 Prism Sequencer. 
 
Microinjection of pUAST-α2NC1: 
 75µg of pUAST-α2NC1 were sent to Genetic Services Inc. for 
microinjection into Drosophila melanogaster embryos. 
 
Genetic Crosses for Overexpression of α2NC1: 
 Each of the five UAS-α2NC1lines was crossed to each of the ten Gal4 
lines shown previously in Table 2.1. Five transgenic males and five virgin Gal4 
females were used in each cross, and crosses were kept at 25oC. Once larvae 
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were observed, the parental flies were transferred to new vials and kept at 29oC. 
After larvae appeared in the 29oC crosses, parental flies were discarded. F1 flies 
were observed using light microscopy and a CO2 plate. 
 
Definition and Synthesis of Leader-α2NC1 (Lα2NC1): 
 In order to create a leader-α2NC1 (Lα2NC1) construct, the online program 
“SignalIP-4.0 Prediction” (http://www.cbs.dtu.dk/services/SignalP/) was used to 
predict collagen IV’s leader sequence. The required Lα2NC1 nucleotide 
sequence was synthesized in vitro as part of a plasmid (pIDTSmart-Lα2NC1). 
15ng of pIDTSmart-Lα2NC1 was used to transform chemically-competent DH5α 
E. coli via heat shock, as previously described. Transformants were selected by 
plating the transformation reaction on LB-agar with 75µg/mL ampicillin and 
growing the cells overnight at 37oC. A single resulting colony was picked and 
used to maxiprep large quantities of pIDTSmart-LαNC1 using the Qiagen Spin 
Maxiprep Kit according to the manufacturer’s protocol.  
 
Cloning of Lα2NC1 into pUAST: 
pIDTSmart-Lα2NC1 and pUAST were each digested with EcoRI (36µg 
pIDTSmart-Lα2NC1 or 21µg pUAST, 3µl EcoRI [~30U, Invitrogen], 8µl 10X 
Buffer H [Invitrogen], nanopure water to 80µl) and run on a 0.8% agarose gel 
with 0.6µg/mL ethidium bromide at 100V for 1hr. The bands corresponding to 
Lα2NC1 (1005bp) and pUAST (~9000bp) were excised, and the DNA was 
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purified by gel extraction using Qiagen’s Qiaex II Gel Extraction Kit according to 
the manufacturer’s protocol. The digested insert and vector were ligated in a 12:1 
ratio (43ng digested pUAST, 57ng digested Lα2NC1, 0.5µl T4 DNA Ligase 
[200U, NEB], 1µl 10X buffer [NEB], nanopure water to 10µl) overnight at 16oC. 
The entire ligation reaction (10µl) was used to transform chemically-competent 
DH5α E. coli via heat shock, as previously described. Transformants were 
selected by growing the cells overnight at 37oC on LB-agar with 75µg/mL 
ampicillin. 
 
Screening of Transformants for Recombinant pUAST-Lα2NC1: 
4mL liquid LB/ampicillin (75µg/mL) cultures were inoculated from each of 
the nineteen resulting transformants and grown overnight at 37oC/300rpm. 
Plasmid DNA was isolated from each of these liquid cultures using Qiagen’s 
QIAprep Spin Miniprep Kit according to the manufacturer’s protocol. Plasmid 
DNA was then digested with BglII (100ng plasmid DNA, 1µl BglII [~5U, 
Invitrogen], 2µl 10X Buffer M [Invitrogen], nanopure water to 20µl) for 2 hours at 
37oC (in a thermal cycler) and run on a 0.8% agarose gel with 0.6µg/mL ethidium 
bromide at 100V for 1hr. Positive clones were identified and large quantities of 
pUAST-Lα2NC1 were generated by maxiprep using Qiagen’s Spin Maxiprep Kit 
according to the manufacturer’s protocol. 
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Standard Dideoxy Sequencing of pUAST-Lα2NC1: 
 Sequencing was conducted following a similar protocol as that used for 
pUAST-α2NC1. ~50ng of pUAST-Lα2NC1 were used in each sequencing 
reaction, and cleanup was achieved by two subsequent isopropanol 
precipitations as follows. Four volumes (40µl) of 75% isopropanol were added to 
the sequencing reaction followed by centrifugation for 20 minutes in a table top 
centrifuge at 21,000Xg. The supernatant was removed and 250µl isopropanol 
added, followed by 10 minutes of centrifugation at 21,000Xg. Once again, the 
supernatant was removed, and residual liquid was evaporated in a centrivap 
vacuum concentrator for 10 minutes at room temperature. Samples were 
resuspended in 20µl of formamide buffer and loaded onto the ABI 3130 Prism 
Sequencer. 
 
Microinjection of pUAST-Lα2NC1: 
 75µg of pUAST-Lα2NC1 were sent to Genetic Services Inc. for 
microinjection into Drosophila melanogaster embryos.
 
 
 
 
 
 
 
 
 
Primer  Use Sequence (5’-3’) 
JO1US Amplification of α2NC1 TGAATTCATGATTGGATTCCAAGGACAG 
JO1DS Amplification of α2NC1 ATTCTAGATTACCTGGACTTTGCAGTGCCG 
UAAS-2 Sequencing ACCAGCAACCAAGTAAATCAACTGC 
pUASTrev Sequencing GTCACACCACAGAAGTAAGG 
 
 
Table 2.1 Primers used for PCR and Sequencing Reactions.  
2
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Gal4 Line Expresses in 
Eyeless-Gal4 Eye 
Panier-Gal4 Dorsal cells 
Scalloped-Gal4 Wing 
Cg-Gal4 Hemocytes 
Vestigial-Gal4 Wing 
Ultra bithorax-Gal4 Thorax, abdomen, wing, haltere 
LSP2-Gal4 Larval fat body/adult hemolymph 
Patched-Gal4 Antero-posterior compartment boundary 
GMR-Gal4 Eye 
Tubulin-Gal4 Whole body 
 
 
Table 2.2. Gal4 Driver Lines. The various driver lines of Drosophila 
melanogaster each express Gal4 in a particular tissue/pattern. Breeding these 
lines with a UAS-transgene line (i.e. UAS-α2NC1), results in progeny that 
overexpress said transgene in the same tissue/pattern (16). 
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CHAPTER 3 
 
RESULTS 
 
 
Successful PCR Amplification of α2NC1 from Viking cDNA: 
 PCR using Viking cDNA as a template successfully amplified the DNA 
fragment corresponding to α2NC1, as shown by the appropriately-sized ~900bp 
band observed following gel electrophoresis of the PCR products (Figure 3.1). 
Furthermore, the primers used were designed such that they incorporated start 
(ATG) and stop (TAA) codons (allowing the α2NC1 gene fragment to be 
translated properly in vivo) as well as restriction sites (forward: EcoRI, reverse: 
XbaI) to be used in future restriction digests (Figure 3.2). The band 
corresponding to the amplified α2NC1 was gel purified for use in the subsequent 
cloning steps. 
 
Cloning of α2NC1 into Bluescript II SK+: 
 Restriction digestion with EcoRI and XbaI resulted in linear Bluescript II 
SK+ (BS), as indicated by the appropriately-sized ~3000bp band observed 
following gel electrophoresis of the completed digest (Figure 3.3). Along with 
double-digested α2NC1 DNA, the linearized BS was used in the subsequent
2
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ligation reaction to generate BS-α2NC1 (Figure 3.4). Heat shock transformation 
of E. coli cells using the ligation reaction resulted in several transformants, as 
indicated by the growth of colonies on selective LB-agar/ampicillin medium. 
 
Screening of Transformants Identified Recombinant BS-α2NC1: 
 Electrophoretic analysis of undigested plasmid DNA isolated from each 
transformant suggested that there were several positive BS-α2NC1 clones, as 
indicated by the shift in molecular weight seen between empty BS and several of 
the samples (Figure 3.5). Digestion of four of these putative BS-α2NC1 samples 
with EcoRI and XbaI confirmed their identity, as gel electrophoresis of each 
digest resulted in two distinct bands, one corresponding to BS (~3000bp) and the 
other to α2NC1 (~900bp) (Figure 3.6). 
 
Subcloning of α2NC1 from BS-α2NC1 to pUAST: 
 Digestion of BS-α2NC1 with EcoRI and XbaI successfully liberated the 
α2NC1 DNA fragment from the vector, as indicated by the two distinct bands 
observed following gel electrophoresis of the completed digest (~900bp and 
~3000bp, corresponding to α2NC1 and BS, respectively) (Figure 3.7). Double-
digestion of pUAST with the same two enzymes successfully linearized the 
vector, as indicated by the ~9000bp band observed following gel electrophoresis 
of the completed digest (Figure 3.7). The digested α2NC1 and pUAST fragments 
were purified from the gel, and used in the subsequent ligation reaction, which 
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resulted in the creation of recombinant pUAST-α2NC1 (Figure 3.8). Heat shock 
transformation of E. coli cells using the ligation reaction resulted in several 
transformants, as indicated by their growth on selective LB-agar/ampicillin 
medium. 
 
Screening of Transformants Identified Recombinant pUAST-α2NC1: 
 Electrophoretic analysis of undigested plasmid DNA isolated from each 
transformant suggested that nearly all transformants were successful pUAST-
α2NC1 clones, as indicated by the shift in molecular weight seen between empty 
pUAST and all but one of the samples (Figure 3.9). PCR amplification of α2NC1 
from one of these putative pUAST-α2NC1 clones confirmed its identity, as gel 
electrophoresis of the PCR product yielded a single band at ~900bp (Figure 
3.10). 
 
Sequencing of pUAST-α2NC1 Revealed that the α2NC1-Coding DNA in the 
Construct is Not Defective: 
 PCR which incorporated fluorescent ddNTPs amplified α2NC1 DNA from 
pUAST-α2NC1, as described in the methods. Half of the reactions utilized primer 
UAAS-2, which anneals to the 5’ side of pUAST’s multiple cloning site, near the 
UAS. The other half of the sequencing reactions used the primer pUASTrev, 
which anneals to the opposite strand of pUAST, just to the 3’ side of the multiple 
cloning site. Sequencing analysis was performed by the ABI 3130 Prism 
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Sequencer. Reverse complementation was performed on results from pUASTrev 
reactions, as this primer amplifies from the nonsense strand. Results were 
compared to the nucleotide sequence “Drosophila melanogaster collagen type IV 
alpha 2 (DmColA2) mRNA, complete cds” using NCBI’s basic local alignment 
search tool (BLAST). Whenever discrepancies were observed between the 
results and accepted sequence, it was determined that the quality of sequencing 
reads for that region was poor and the sequence was confirmed by proper 
alignment in duplicate runs (see example, Figure 3.11). It was ultimately 
determined that no errors in cloning or mutations had occurred, and that the 
vector contained the proper coding sequence for α2NC1 as well as flanking start 
and stop codons. 
 
Generation of UAS-α2NC1 Flies: 
pUAST-α2NC1 was sent to Genetic Services Incorporated (GSI) where, 
along with a transposase element, it was microinjected into the germ line cells of 
Drosophila embryos. Because pUAST contains a P-element, microinjection 
resulted in the incorporation of the vector into the fly genome. Inbreeding of these 
initial transgenics resulted in animals with the insert present in the genomic DNA 
of every cell and tissue. Five viable transgenic UAS-α2NC1 lines (referred to as 
“JO1” lines) were received from GSI, of which two were homozygous for UAS-
α2NC1 on the second chromosome and two were homozygous for UAS-α2NC1 
on the third chromosome. An additional second chromosome line was 
homozygous lethal and therefore balanced over CyO on the second 
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chromosome (Table 3.1). Each of these transgenic lines should enable the 
overexpression of α2NC1, which for the purposes of these experiments was 
defined as amino acids 1450-1749 of the 1761 amino acid collagen IV α2 protein. 
These residues contain both α2NC1 and provide extra “contextual” amino acids 
that may help maintain α2NC1’s normal folding  
 
Overexpression of α2NC1 in Flies Produces No Developmental Phenotype: 
Various Gal4 driver lines of Drosophila melanogaster are available which 
drive expression of Gal4 in a tissue-specific pattern. These Gal4 driver lines 
contain the gene for Gal4 under the control of various enhancers. Each driver 
line therefore expresses Gal4 in a specific pattern based upon its unique 
enhancer. For example, vestigial (vg) is a gene expressed primarily in the wing 
imaginal disc, along the ventral-dorsal compartment boundary (19). Vg-Gal4 flies 
therefore express Gal4 in a similar pattern within the wing. By crossing UAS-
α2NC1 flies with various Gal4 driver lines, the expression of α2NC1 should follow 
the same pattern as the Gal4 expression. This allowed us to investigate any 
tissue specific effects of α2NC1’s expression. This is an important question to 
ask, given that BM composition differs greatly between various organs and 
tissues (2,3). 
Crosses between the Gal4 drivers lines shown in Table 2.1 and the five 
JO1 lines produced no developmental phenotype at 25oC. Crosses conducted at 
29oC similarly showed no outstanding characteristics, despite the fact that the 
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Gal4 system is temperature sensitive and overexpresses more at higher 
temperatures. This lack of effect is likely due to a requirement for extracellular 
localization of α2NC1 for its functionality. This possibility will be investigated in 
future crosses between UAS-Lα2NC1 (JO2) and Gal4 lines, as these progeny 
will overexpress a secreted version of α2NC1. 
 
Definition and Synthesis of Leader-α2NC1 (Lα2NC1): 
SignalIP-4.0 Prediction indicated collagen IV α2’s signal peptidase 
cleavage site as being between amino acids 28 and 29 (Figure 3.12). In order to 
conserve the context of the cleavage site, amino acids 1-35 were chosen to be 
joined to aa1450-1749 (α2NC1) of collagen IV. The Lα2NC1 DNA sequence was 
created in vitro by Integrated DNA Technologies (IDT) as part of a simple 
plasmid (pIDTSmart-Lα2NC1). 
The fusion of the leader sequence to α2NC1 should result in the 
cotranslational localization of the peptide to the rough endoplasmic reticulum. 
Once fed into the ER lumen, α2NC1 will be cleaved from the membrane-bound 
leader sequence by signal peptidase. Like other soluble ER-localized peptides, 
α2NC1 will be directed to the Golgi apparatus and eventually to the plasma 
membrane for export from the cell to its native extracellular location. 
 
Cloning of Lα2NC1 into pUAST: 
 Digestion with EcoRI liberated the Lα2NC1 DNA fragment from 
pIDTSmart-Lα2NC1, as indicated by the two distinct bands observed following 
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gel electrophoresis of the completed digest (~1005bp and ~2000bp, 
corresponding to Lα2NC1 and pIDTSmart, respectively) (Figure 3.13). Digestion 
of pUAST with EcoRI successfully linearized the vector, as indicated by the 
~9000bp band observed following gel electrophoresis of the completed digest 
(Figure 3.13). These digested fragments were gel purified and used in the 
subsequent ligation reaction which resulted in the successful creation of 
recombinant pUAST-Lα2NC1 (Figure 3.14). Heat shock transformation of E. coli 
cells using the ligation reaction resulted in several transformants, as indicated by 
their growth on selective LB-agar/ampicillin medium. 
 
Screening of Transformants Identified Recombinant pUAST-Lα2NC1: 
Digestion of plasmid DNA isolated from each transformant identified one 
as containing recombinant pUAST-Lα2NC1, as digestion with BglII followed by 
gel electrophoresis resulted in two visible bands, one corresponding to pUAST 
(~9000bp) and the other to Lα2NC1 (1005bp) (Figure 3.15). This restriction 
pattern indicated that Lα2NC1 had inserted in the forward orientation relative to 
the UAS in pUAST (Figure 3.16). 
 
Sequencing of pUAST-Lα2NC1 Revealed that the Lα2NC1-Coding DNA in 
the Construct is Not Defective: 
 Sequencing of pUAST-Lα2NC1 was performed in a manner similar to that 
used for pUAST-α2NC1. Results were compared using BLAST to the nucleotide 
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sequences “Drosophila melanogaster collagen type IV alpha 2 (DmColA2)” and 
“viking, transcript variant C” to verify the integrity of the α2NC1 and leader 
sequences within pUAST-Lα2NC1. Using the analysis strategy described for 
pUAST-α2NC1, it was determined that this construct contained the proper 
genetic sequences for both the leader sequence and α2NC1 (Figure 3.17). 
 
Generation of UAS-Lα2NC1 Flies: 
 pUAST-Lα2NC1 DNA was sent to Genetic Services Incorporated (GSI) 
where, it was microinjected into Drosophila embryos, as described for the 
microinjection of pUAST-α2NC1. These flies will contain a leader-α2NC1 fusion 
sequence, again under the control of a UAS. The added leader sequence should 
direct the overexpressed α2NC1 peptide to the endoplasmic reticulum so that it 
can be exported from the cell to its native extracellular location. 
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Figure 3.1. PCR Amplification of α2NC1 DNA. PCR successfully amplified the 
genetic sequence for α2NC1. The PCR products were run on a 0.8% agarose gel 
with 0.6µg/mL at 100V for 1hr, which yielded a single band of the appropriate 
size (~900bp) (lanes 3 and 5). Lane 1 contains a standard 1kB+ DNA Ladder 
(Invitrogen). The PCR product was excised and subsequently purified using 
Qiagen’s Qiaex II Gel Extraction Kit.  
 
 
850bp 
1000bp 
     1           2               3             4              5              6 
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Figure 3.2. Primers Used to Amplify α2NC1 from Viking Incorporated Start/Stop Codons and Restriction 
Sites. The primers shown above were designed to anneal to the forward and reverse strands of Viking cDNA , 
flanking the base pairs corresponding to amino acids 1450-1749 (NC1) of collagen IV α2. The forward primer 
incorporated a start codon (ATG) and EcoRI restriction site (GAATTC). The reverse primer incorporated a stop 
codon (TTA-reverse complement) and XbaI restriction site (TCTAGA). Figure not to scale. 
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Figure 3.3. Double-Digestion of BS and α2NC1. 40µg of BS and 1µg of PCR-
amplified α2NC1 DNA were digested with EcoRI and XbaI. Digests were run on a 
0.8% agarose gel with 0.6µg/mL ethidium bromide at 100V for 1hr. Lanes 1-3 
contain digested α2NC1. Lanes 4-6 contain digested (linear) BS. Digested BS 
and α2NC1 DNA were purified from the gels using Qiagen’s Qiaex II Gel 
Extraction Kit for use in the subsequent ligation reaction to create BS-α2NC1. 
      1          2          3          4          5          6 
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Figure 3.4. BS-α2NC1. Bluescript was used as an initial carrier for the α2NC1 
genetic sequence, as it is much smaller than pUAST and therefore easier to use 
in the cloning reaction. The completed BS-α2NC1 plasmid contained an 
ampicillin resistance gene in addition to a bacterial origin of replication and the 
inserted α2NC1 genetic sequence, which was flanked by EcoRI and XbaI sites. 
Large quantities of BS-α2NC1 were generated and digested in order to produce 
the α2NC1 DNA needed for cloning into pUAST (20) 
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Figure 3.5. Putative BS-α2NC1 Clones. Plasmid DNA isolated from various 
clones via miniprep was run on a 0.8% agarose gel at 100V for 1hr. For 
comparison, lane 2 contains supercoiled BS DNA. The gel shift seen between 
the bands in lane 2 and those in lanes 3-9, 13, 15, and 16 indicates that these 
are most likely recombinant (BS-α2NC1) molecules. Lanes 10, 12, and 14 
appear to contain empty vector, and the molecule represented in lane 11 is 
possibly a BS molecule that incorporated two copies of α2NC1. Lane 17 contains 
nanopure H2O. 
  
  1      2     3      4     5      6      7     8      9    10    11   12    13    14   15   16   17 
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Figure 3.6. Digestion of Putative BS-α2NC1 Clones. Four putative BS-α2NC1 
clones (see Figure  3.5) were digested with EcoRI and XbaI in order to liberate 
the incorporated α2NC1 fragment and confirm their identity. Digests were run on 
a 0.8% agarose gel with 0.6µg/mL at 100V for 1hr. For comparison, lane 2 
contains digested BS (empty). Lanes 3-5 are clearly BS-α2NC1, as bands 
corresponding to BS (~3000bp) and α2NC1 (~900bp) are easily visible. The 
clone represented in lane 6 is also most likely BS-α2NC1, but the presence of an 
additional band just below 3000bp raises some question; the additional band is 
most likely a result of star activity, which was seen in some other digests due to 
the fact that EcoRI functions non-ideally in the medium-salt XbaI buffer that was 
used for the double-digestion. The clone represented in lane 4 was selected for 
future use. 
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Figure 3.7. Double-Digestion of pUAST and BS-α2NC1. 42.5µg of pUAST and 
47.3µg of BS-α2NC1 were digested with EcoRI and XbaI. Each digest was run 
on a 0.8% agarose gel with 0.6µg/mL at 100V for 1hr. A) Lanes 3-5 contain 
digested (linear) pUAST. Lane 6 contains nanopure water. B) Lanes 2-5 contain 
digested BS-α2NC1 (upper band is linear BS ~3000bp and lower band is α2NC1 
~900bp). Lane 6 contains nanopure water. Digested pUAST and α2NC1 DNA 
was purified from the gels using Qiagen’s Qiaex II Gel Extraction Kit for use in 
the subsequent ligation reaction to create pUAST-α2NC1. 
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Figure 3.8. pUAST-α2NC1. This vector contained a gene for ampicillin 
resistance, a bacterial origin of replication, and the gene fragment for α2NC1 just 
downstream of the UAS (“5xGal4 DBD”). This vector was microinjected into 
Drosophila embryos, and due to its P element capability, it integrated into the 
genome, resulting in five lines of UAS-α2NC1 or “JO1” flies (20)
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Figure 3.9. Putative pUAST-α2NC1 Clones. Plasmid DNA isolated from various 
clones via miniprep was run on a 0.8% agarose gel with 0.6µg/mL at 100V for 
1hr. For comparison, lane 1 contains supercoiled pUAST DNA. The gel shift seen 
between the bands in lane 1 and those in lanes 2-8 and 10-19 indicates that 
these are most likely recombinant (pUAST-α2NC1) molecules. The identity of the 
band in lane 9 is unknown. 
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Figure 3.10. PCR Amplification of α2NC1 from a Putative Clone Confirms Its 
Identity as pUAST-α2NC1. PCR successfully amplified the α2NC1 genetic 
sequence from one of the putative pUAST-α2NC1 clones seen in Figure 3.6. The 
PCR products were run on a 0.8% agarose gel with GelRed (Biotium) at 100V for 
1hr, and the ~900bp band corresponding to α2NC1 is easily visible in lane 2. 
Lane 1 contains a 1kB+ DNA Ladder (Invitrogen). 
 
1000bp 
850bp 
    1          2           
  
Drosophila melanogaster collagen type IV alpha 2 (DmColA2) mRNA, complete cds 
 
Query  88    ACAGAGAGGTGCCGTCGGATATCGCGCCCGACCAGGGCGAGGTGGGCTACACCGGAGCCG  147 
             ||||||||||||||||||||||||||   ||||||||||||||||||||||||||||||| 
Sbjct  4509  ACAGAGAGGTGCCGTCGGATATCGCG-GTGACCAGGGCGAGGTGGGCTACACCGGAGCCG  4567 
 
 
Figure 3.11. Sequencing of pUAST-α2NC1. Above are representative sequencing results for pUAST-α2NC1. 
Results were compared using BLASTn to “Drosophila melanogaster collagen type IV alpha 2 (DmColA2) mRNA, 
complete cds.” Mismatches typically corresponded to poor sequencing reads (see yellow highlighted reads above). 
Duplicate sequencing reactions were performed in order to obtain enough good reads to confirm that the entire 
α2NC1 sequence was correct. 
4
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Figure 3.12. Cleavage Prediction. The online “SignalIP-4.0 Prediction” software was used to predict which amino 
acids comprise the leader peptide that targets collagenIVα2 for translation at the rough ER and eventual secretion 
from the cell. The output above shows three scores. The C score is highest at the position predicted to be just after 
the cleavage site. The S score (green) is high for those residues thought to comprise the leader sequence. The Y 
score (blue) is a combination of the C and S scores and peaks at the most likely cleavage sites. Based on this 
output, the most likely cleavage site is between residues 27 and 28, with a second potential site between residues 
30 and 31. As such, amino acids 1-35 were chosen for fusion with the C-terminal α2NC1 domain. When this fused 
protein (Lα2NC1) is expressed in vivo, the leader should be cleaved off by a signal peptidase in the ER, and 
α2NC1 will be exported to the extracellular space where it can enact its biological functions. 
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Figure 3.13. Digestion of pIDTSmart-Lα2NC1 and pUAST. pIDTSmart-
Lα2NC1 and pUAST were digested with EcoRI. Each digest was run on a 0.8% 
agarose gel with 0.6µg/mL ethidium bromide at 100V for 1hr. Lane 1 contains a 
standard 1kb+ DNA ladder (Invitrogen). Lanes 2 and 3 contain digested 
pIDTSmart-Lα2NC1 (upper band is linear pIDTSmart (~2000bp) and lower band 
is Lα2NC1 ~1000bp). Lanes 4 and 5 contain digested (linear) pUAST (~9000bp). 
Lane 6 contains nanopure water. Digested pUAST and Lα2NC1 DNA was 
purified from the gel using Qiagen’s Qiaex II Gel Extraction Kit for use in the 
subsequent ligation reaction to create pUAST-Lα2NC1. 
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Figure 3.14. pUAST-Lα2NC1. This vector contained a gene for ampicillin 
resistance, a bacterial origin of replication, and the genetic sequence coding for a 
leader peptide and α2NC1 (Lα2NC1) just downstream of the UAS (“5xGal4 
DBD”). This vector was sent to Genetic Services Incorporated for microinjection 
into Drosophila embryos, and due to its P element capability, it will integrate into 
the genome, resulting in transgenic lines of UAS-Lα2NC1 or “JO2” flies (20) 
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Figure 3.15. Digestion of Potential pUAST-Lα2NC1 Clones. Eighteen putative 
BS-α2NC1 clones (only 6 shown) were digested with BglII in order to liberate the 
incorporated Lα2NC1 fragment and so identify any recombinant (pUAST-
Lα2NC1) molecules. Digestion with BglII (as opposed to the enzyme used to 
clone [EcoRI]) allowed for directional screening, to ensure proper orientation of 
the inserted Lα2NC1 fragment (see Figure 2.2). Digests were run on a 0.8% 
agarose gel with 0.6µg/mL ethidium bromide at 100V for 1hr. Lane 1 contains a 
standard 1kB+ DNA ladder (Invitrogen). For comparison, lane 2 contains 
digested pUAST (empty). Lane 4 is clearly pUAST-Lα2NC1, as bands 
corresponding to pUAST (~9000bp) and Lα2NC1 (1005bp) are easily visible. 
Lanes 5-9 appear to be empty pUAST. Lane 10 is nanopure water. 
  
1000bp 
850bp 
  1     2     3     4      5     6     7     8     9    10 
  
 
 
 
Figure 3.16. Digestion with BglII Can Identify Orientation of LαNC1. The construct on the left shows Lα2NC1 in 
the proper orientation relative to the UAS (“5XGal4 DBD”). As shown by the marked restriction sites, digestion of 
this molecule with BglII would result in three fragments, 80bp, 914bp, and 8921bp. If Lα2NC1 inserted in the 
reverse orientation (right), fragments 80bp, 29bp, and 9806bp long would be expected following BglII digestion (20) 
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Drosophila melanogaster collagen type IV alpha 2 (DmColA2) mRNA, complete cds 
 
Leader:  Query  67   ATGTTACCCAGAGAACAAAGGGATCTCTCGGGTCTTCTGGGCGTCGTTTATCTGTTGGGC  126 
              |||||||||||||| | |||| ||||||||||||||| |||||||||||||||||||||| 
  Sbjct  154  ATGTTACCCAGAGATCTAAGGCATCTCTCGGGTCTTCCGGGCGTCGTTTATCTGTTGGGC  213 
 
α2NC1:  Query  172  ATTGGATTCCAAGGACAGAGAGGTGCCGTCGGATATCGCGGTGACCAGGGCGAGGTGGGC  231 
              |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
  Sbjct  4495 ATTGGATTCCAAGGACAGAGAGGTGCCGTCGGATATCGCGGTGACCAGGGCGAGGTGGGC  4554 
 
 
Figure 3.17. Sequencing of pUAST-Lα2NC1. Above are representative sequencing results for pUAST-Lα2NC1. 
Results were compared using BLASTn to “Drosophila melanogaster collagen type IV alpha 2 (DmColA2) mRNA, 
complete cds.” Mismatches typically corresponded to poor sequencing reads (see yellow highlighted reads above). 
Duplicate sequencing reactions were performed in order to obtain enough good reads to confirm that both parts of 
the Lα2NC1 sequence were correct.
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Line Chromosome 
JO1L1 III, homozygous 
JO1L2 III, homozygous 
JO1L3 II, homozygous 
JO1L4 II, balanced over CyO 
JO1L5 II, homozygous 
 
 
Table 3.1. JO1 Transgenic Lines. Five lines of transgenic Drosophila 
melanogaster were received from Genetic Services Incorporated following 
microinjection of pUAST-α2NC1. 
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CHAPTER 4 
 
 
DISCUSSION 
 
 
 Three recombinant vectors were generated as a result of this work. The 
first of these (BS-α2NC1) was generated by cloning of the genetic sequence for 
α2NC1 into the multiple cloning site of the common laboratory vector Bluescript II 
SK+. α2NC1 DNA was generated by PCR amplification of corresponding region 
from Viking cDNA (Viking being the Drosophila melanogaster gene for the full α2 
chain of collagen IV). The primers used for PCR were designed to incorporate 
start and stop codons (allowing the α2NC1 gene fragment to be translated 
properly in vivo) as well as restriction sites (EcoRI and XbaI, to be used in 
cloning) on either side of the α2NC1 sequence. Double-digestion of the PCR 
product and Bluescript SK+ with said enzymes, followed by ligation using T4 
DNA ligase, successfully produced the recombinant BS-α2NC1 molecule. 
 The second vector was pUAST-α2NC1, which was generated by 
subcloning of the α2NC1 genetic sequence from BS-α2NC1 to the Drosophila 
vector pUAST. Digestion of pUAST and excision of α2NC1 from BS-α2NC1 were 
carried out using the same enzymes as before (EcoRI and XbaI), ensuring that 
αNC1 was ligated into pUAST in the forward orientation relative to pUAST’s 
upstream activation sequence (UAS).
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The third and final construct, pUAST-Lα2NC1, contained the genetic 
sequence for a leader-α2NC1 fusion construct under the control of pUAST’s 
UAS. The native α2-chain leader sequence was determined, and the Lα2NC1 
fusion sequence (with flanking EcoRI sites) was synthesized in vitro as part of a 
simple bacterial plasmid. Restriction digestion with EcoRI excised the Lα2NC1 
fragment from said plasmid, and ligation with EcoRI-digested pUAST resulted in 
recombinant pUAST-Lα2NC1. Due to the use of a single enzyme in this cloning 
procedure, several plasmid molecules resulting from the ligation were merely 
empty pUAST that had not incorporated an insert, and one was found to be 
pUAST that incorporated Lα2NC1 in the reverse orientation relative to the UAS. 
However, a second round of ligation resulted in a pUAST-Lα2NC1 molecule with 
Lα2NC1 in the proper orientation. 
The two pUAST constructs were sent to Genetic Services Incorporated 
where they were microinjected into Drosophila melanogaster embryos, resulting 
in transgenic animals containing α2NC1 under the control of an upstream 
activation sequence (UAS). Five lines of UAS-α2NC1 (JO1) flies were received 
from GSI (see Table 3.1), and mapped UAS-Lα2NC1 (JO2) lines are expected to 
be received in the near future. 
 The creation of these transgenic lines is the first critical step in this study 
of α2NC1 in organismal development and tumorigenesis, as they have and will 
allow for the Gal4-dependent tissue-specific overexpression of α2NC1 in wild-
type and tumor-bearing flies. Crosses between each of the five UAS-α2NC1 
(JO1) lines and ten different Gal4 driver lines (see Tables 3.1 and 1.1) all 
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produced viable offspring with no observed phenotypic abnormalities. The 
absence of an effect was surprising; it was expected that, given the critical role of 
BM in Drosophila development, perturbing its composition would result in lethality 
or improper/incomplete development of various structures, depending on the 
expression pattern in question. 
However, there are potential explanations for the lack of developmental 
phenotype. First, in order to rule out the possibility that α2NC1 was not being 
overexpressed as expected, reverse transcription PCR will be used to quantify 
α2NC1 RNA levels in overexpressing versus wild type flies. Assuming that 
α2NC1 levels are indeed significantly more robust in the overexpressing flies, 
one likely reason for the lack of phenotype could be the improper localization of 
α2NC1 from UAS- α2NC1. Because basement membrane is extracellular in 
nature and because α2NC1 is derived from the BM, it is logical to infer that 
α2NC1 should be localized to the outside of the cell. The extracellular localization 
of collagen IV is dependent on the N-terminal signal peptide. However, α2NC1 is 
a C-terminal domain of collagen IV, and as part of the UAS- α2NC1 construct 
does not contain the amino acid sequence that directs the α-chain to the 
endoplasmic reticulum during translation and thereby targets it for secretion from 
the cell. Therefore, it is very likely that the recombinant α2NC1 being 
overexpressed in the JO1 X Gal4 progeny is located in the cytoplasm where it is 
unable to exert its effects (such as binding to the extracellular domains of α3 and 
αv integrins). In the near future, crosses between UAS-Lα2NC1 (JO2) and Gal4 
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flies will test this hypothesis, as these progeny will overexpress a leader 
sequence-α2NC1 fusion molecule that will target α2NC1 for secretion. 
 In said JO2 X Gal4 crosses, it is expected that distinct developmental 
abnormalities will be observed as a result of abundant extracellular α2NC1 
which, based upon previous work, is likely to disrupt formation of basement 
membrane and decrease branching of the tracheal system. Branching of the 
tracheal system (whose vessels deliver oxygen to various tissues) in Drosophila 
has been shown to be in many ways homologous to the mammalian process of 
angiogenesis (21). For this reason, the list of Gal4 drivers may be expanded to 
include a btl-Gal4 line which will drive expression of α2NC1 in the tracheal cells 
themselves. Furthermore, in order to test the hypothesis that α2NC1 
overexpression (resulting from JO2 X Gal4 crosses) will diminish formation of 
tracheal vessels, studies may be conducted in which larvae are stained via 
immunohistochemistry with a labeled anti-2A12 antibody, a marker used in other 
studies to specifically identify tracheal cells (22). 
 In tumorigenesis studies, it is expected that α2NC1 overexpression will 
result in fewer and smaller tumors (again likely due to disrupted BM formation 
and decreased tracheal branching), and future experiments will work to 
investigate the mechanism of such results. 
 Other future studies may involve the creation of α2NC1 transgenics with a 
fluorescent or antigen tag, so that localization of α2NC1 can be seen within the 
fly and on a smaller scale, it’s (extra)cellular location. Furthermore, we would like 
to conduct further overexpression studies in order to investigate the 
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developmental and tumorigenic roles of other collagen IV fragments (such as the 
N-terminal 7S domain) as well as other basement membrane molecules; for 
example, collagens, laminin, SPARC, and perlecan, have all been shown in other 
studies to be bioactive and regulators of angiogenesis (2,3). 
 These investigations will shed light upon the numerous interactions that 
take place during basement membrane remodeling, both in normal 
developmental situations and during the invasive processes of tumor 
angiogenesis and metastasis, and thus will contribute toward the ultimate goal of 
fully understanding and combating tumor development and progression in 
patients diagnosed with cancer.
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ABBREVIATIONS NOT LISTED IN TEXT 
 
 
SPARC................................................ secreted protein acidic and rich in cysteine 
FLIP............................................................................ FLICE-like inhibitory protein 
FAK...................................................................................... focal adhesion kinase 
PI3K............................................................................... phosphoinositide 3-kinase 
Bcl-2......................................................................... B-cell lymphoma 2 (a protein) 
Bax................................................................................ Bcl-2-associated X protein 
PCR.............................................................................. polymerase chain reaction 
dNTP.................................................................. dexoyribonucleotide triphosphate 
LB....................................................................................................... Luria-Bertani 
ddNTP............................................................. dideoxyribonucleotide triphosphate 
 
